CAS RN: 1310732-18-3
tert-Butyl 3-(chlorosulphonyl)azetidine-1-carboxylate, 1-(tert-Butoxycarbonyl)-3-(chlorosulphonyl)azetidine
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250612 |
100mg / 250mg / 500mg / 1g |
Confirm by inquiry |
Shanghai | 5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 1g, 5g, 0.25g, 10g
- Available purity: ≥95%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1310732-18-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥95% |
5
In Stock
|
Beijing |
Inquiry |
| 1g |
≥95% |
5
In Stock
|
Shenzhen |
Inquiry |
| 5g |
≥95% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
≥95% |
4
In Stock
|
Beijing |
Inquiry |
| 10g |
≥95% |
2
In Stock
|
Beijing |
Inquiry |
1310732-18-3 / tert-butyl 3-chlorosulfonylazetidine-1-carboxylate
Standard CAS: 1310732-18-3
Multi CAS: No
Basic Information
CAS
1310732-18-3
Multi CAS
No
Molecular Formula
C8H14ClNO4S
Molecular Weight
255.720000
Exact Mass
255.033207
SMILES
CC(C)(C)OC(=O)N1CC(C1)S(=O)(=O)Cl
InChI
InChI=1S/C8H14ClNO4S/c1-8(2,3)14-7(11)10-4-6(5-10)15(9,12)13/h6H,4-5H2,1-3H3
InChIKey
AZNUWDVFBPYWSU-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
15
Fraction Csp3
0.88
Rotatable bonds
1
H-bond acceptors
4
Molar refractivity
56.37
TPSA
63.68
LogP / Solubility
WLOGP
1.17
MLOGP
1.04
XLogP3
1.1
Consensus LogP
1.1
Log S (ESOL)
-2.1
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.5
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.42
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.45
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5
Safety & Transport
Pictogram(s)
Corrosive
Signal
Danger
GHS Hazard Statements
H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
Precautionary Statement Codes
P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501